GLUCOCORTICOIDS IN CHRONIC INFLAMMATORY DISEASES: ASSESSMENT OF PATIENTS’ ADHERENCE
4CPS-043
EVALUATION OF NON-FORMULARY DRUGS PRESCRIPTION AND ACCEPTANCE OF AN ALTERNATIVE DRUG
4CPS-038
INITIAL EXPERIENCE WITH THE USE OF PCSK9- INHIBITORS IN THE REAL-WORLD CLINICAL PRACTICE
4CPS-036
STATINS AND THE ELDERLY: IS THEIR USE APPROPRIATE?
4CPS-033
EFFECTIVENESS OF THERAPEUTIC INTERCHANGE PROGRAMMES FOR ANGIOTENSIN RECEPTOR BLOCKERS IN THE HOSPITAL SETTING
4CPS-030
EVALUATION OF PHARMACIST-LED CARDIOVASCULAR SERVICES WITHIN PRIMARY CARE, PROVIDED BY CARDIOVASCULAR PHARMACISTS
4CPS-027
HOSPITAL PHARMACIST INTERVENTIONS IN AN ACCREDITED CARDIOLOGY DEPARTMENT
4CPS-026
THE SACUBITRIL-VALSARTAN ASSOCIATION: FROM THEORY TO PRACTICE
4CPS-022
PREVALENCE OF POTASSIUM, PHOSPHORUS AND CALCIUM IMBALANCE IN VERY-LOW-BIRTHWEIGHTPRETERM INFANTS RECEIVING PARENTERAL NUTRITION FROM THE FIRST DAY OF LIFE
4CPS-021
TREATMENT OF PREOPERATIVE ANAEMIA WITH FERRIC CARBOXYMALTOSE
4CPS-019
EVALUATION OF VENOUS THROMBOEMBOLIC EVENT PROPHYLAXIS IN HOSPITALISED CANCER PATIENTS: A SINGLE-CENTRED RETROSPECTIVE STUDY
4CPS-004
RELEVANCE OF PROTON PUMP INHIBITOR (PPI) TREATMENTS IN 2017 IN TWO GERIATRIC DEPARTMENTS: IMPACT OF A FIRST STUDY IN 2014 ON PRESCRIBING PRACTICES
4CPS-225
DEVELOPMENT OF A DRUG INFORMATION SHEET FOR PATIENTS TO PROMOTE APPROPRIATE USE
4CPS-061
ANTIBIOTIC PROPHYLAXIS FOR PREVENTING SURGICAL WOUND INFECTION AFTER ELECTIVE CAESAREAN SECTION: META-ANALYSIS OF CLINICAL TRIALS
4CPS-165
ESTIMATION OF PRECISION AND ACCURACY OF FIVE POPULATION PHARMACOKINETICS MODELS OF INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
